The Biocidal Products Committee adopted the opinion of BKC/ADBAC (Benzalkonium chloride – CAS 68424-85-1) and DDAC (Didecyldimethylammonium chloride – CAS 7173-51-5) for Product Type 3 and 4. All companies interested in placing new products or keeping existing products on the market within PT3 and/or 4 applications, should think about their strategy to register these products under BPR.

Will your company go for submission as an individual dossier? Does your company have a range of products, which could fit the latest family concept? Or would your company consider binding forces with other companies, by joining a consortium? ARCHE Consulting has ongoing pre-consortia for both active substances and can assist you in finding the best option for your situation. If you want more information, feel free to contact us!